Company intelligence / Profile preview
GP Pharm
Barcelona, Catalonia, Spain
- Ownership
- Private
- Development stage
- Other
01
Overview
Lutrate® (leuprolide acetate microsphere) is approved and commercialized in Europe for prostate cancer; octreotide depot for acromegaly is approved. Sarcodoxome® (liposomal doxorubicin) in development; multiple generic cytotoxics are registered or in late-stage development. The company conducts clinical trials and registration programs in multiple therapeutic areas. Lutrate one-month pending registration in further jurisdictions; Lutrate three-month in Phase 3, Lutrate six-month in pre-clinical. Six active/interventional clinical trials as of 2025, with positive results in testosterone suppression and depot formulation safety.
- Therapeutic areas
- NephrologyCardiovascularEndocrinologyGastroenterologyNeurologyPsychiatryOncology
- Modalities
- Small moleculeSynthetic peptideMonoclonal antibodyLiposomeMicrospheres
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Sigma-Tau (Italy, cardiovascular and prostate cancer)Cephalon (US, manufacturing Myocet)PharmaMar (Lurbinectedin partnership)Oncológica consortium (collaborative cancer R&D, multiple Spanish pharma/biotech)
Beyond the preview
Go deeper on GP Pharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GP Pharm.